Tesamorelin vs Sermorelin
Sermorelin is an older GHRH analogue comprising the first 29 amino acids of endogenous GHRH — sufficient for GHRH receptor binding and activation. It was the first GHRH analogue to receive FDA approval (for pa…
Comparison
Tesamorelin UK: Topic comparisons
Approved comparison material connected to this topic.
4 total recordsSide-by-side reading
Comparison records
Source comparisons are presented without a generated winner.
Read comparison →
2. Molecular structure — full-length GHRH vs CJC-1295
Tesamorelin is [trans-3-hexenoyl]-hGHRH(1-44)-NH₂ — the 44-amino-acid native human GHRH sequence with a trans-3-hexenoyl (a C6 unsaturated acyl) group attached to the N-terminal tyrosine. Molecular weight 5196…
10. Pulsatility preservation vs CJC-1295 with DAC
Tesamorelin’s ~30-40 minute half-life preserves physiological GH pulsatility when dosed once daily — the GH pulse occurs within the first 1-3 hours post-injection and returns to baseline. This is unlike CJC-12…
Tesamorelin vs CJC-1295
CJC-1295 is a GHRH analogue incorporating drug affinity complex (DAC) technology that enables albumin binding, extending its half-life to approximately 6–8 days and permitting once- or twice-weekly dosing rath…